Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples